SETDB1 as a cancer target: challenges and perspectives in drug design
Article in RSC Medicinal Chemistry (May 2024)
The most recent citing publications are shown below. View all 35 publications that cite this research output on Dimensions.
Identification of differentially expressed mRNA/lncRNA modules in acutely regorafenib-treated sorafenib-resistant Huh7 hepatocellular carcinoma cells
Article in PLOS ONE (April 2024)
KLF7 regulates super-enhancer-driven IGF2BP2 overexpression to promote the progression of head and neck squamous cell carcinoma
Article in Journal of Experimental & Clinical Cancer Research (March 2024)